Literature DB >> 25047674

EGFR-mutated lung cancer in Li-Fraumeni syndrome.

Vasiliki Michalarea1, Matthew Calcasola2, Paul Cane3, Khalid Tobal4, Louise Izatt5, James Spicer6.   

Abstract

This is a revised case report of a 52 year old Caucasian female with Li-Fraumeni syndrome with a rare TP53 mutation, who was treated for breast cancer and later developed epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer. Crown
Copyright © 2014. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  EGFR mutations; Li-Fraumeni syndrome; Non-small cell lung cancer; TP53

Mesh：

Substances：

Year:  2014        PMID： 25047674     DOI： 10.1016/j.lungcan.2014.06.017

Source DB:  PubMed          Journal:  Lung Cancer        ISSN： 0169-5002            Impact factor:   5.705


  8 in total

1.  Breast Cancer Patient with Li-Fraumeni Syndrome: A Case Report Highlighting the Importance of Multidisciplinary Management.

Authors:  Beatriz Cirauqui; Teresa Morán; Anna Estival; Vanesa Quiroga; Olatz Etxaniz; Carmen Balana; Matilde Navarro; Salvador Villà; Rosa Ballester; Mireia Margelí
Journal:  Case Rep Oncol       Date:  2020-02-13

2.  Lung Cancer in Li-Fraumeni Syndrome.

Authors:  Kathleen Kerrigan; Jessica Chan; Jennie Vagher; Wendy Kohlmann; Anne Naumer; Jo Anson; Sara Low; Joshua Schiffman; Luke Maese
Journal:  JCO Precis Oncol       Date:  2021-03-23

3.  Hormone receptor expression correlates with EGFR gene mutation in lung cancer in patients with simultaneous primary breast cancer.

Authors:  Zhihuang Hu; Xuan Zou; Shanshan Qin; Yuan Li; Huijie Wang; Hui Yu; Si Sun; Xianghua Wu; Jialei Wang; Jianhua Chang
Journal:  Transl Lung Cancer Res       Date:  2020-04

Review 4.  Inherited lung cancer: a review.

Authors:  Viviane Teixeira Loiola de Alencar; Maria Nirvana Formiga; Vladmir Cláudio Cordeiro de Lima
Journal:  Ecancermedicalscience       Date:  2020-01-29

Review 5.  Potential genetic modifiers for somatic EGFR mutation in lung cancer: a meta-analysis and literature review.

Authors:  Yue I Cheng; Yun Cui Gan; Dan Liu; Michael P A Davies; Wei Min Li; John K Field
Journal:  BMC Cancer       Date:  2019-11-08       Impact factor: 4.430

6.  Prevalence of the Brazilian TP53 Founder c.1010G>A (p.Arg337His) in Lung Adenocarcinoma: Is Genotyping Warranted in All Brazilian Patients?

Authors:  Igor Araujo Vieira; Tiago Finger Andreis; Bruna Vieira Fernandes; Maria Isabel Achatz; Gabriel S Macedo; Daniel Schramek; Patricia Ashton-Prolla
Journal:  Front Genet       Date:  2021-02-02       Impact factor: 4.599

7.  Distinct NSCLC EGFR Variants in a Family With Li-Fraumeni Syndrome: Case Report.

Authors:  Shelby Edmondson; Mitchell S von Itzstein; Brian Reys; Melissa Mayer; Jeffrey Gagan; David E Gerber
Journal:  JTO Clin Res Rep       Date:  2022-06-25

8.  Germline TP53 Mutation and Clinical Characteristics of Korean Patients With Li-Fraumeni Syndrome.

Authors:  Kyoung Jin Park; Hyun Jung Choi; Soon Pal Suh; Chang Seok Ki; Jong Won Kim
Journal:  Ann Lab Med       Date:  2016-09       Impact factor: 3.464
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.